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The lowering of maternal 1,25(OH),D3 concentration by these treatments was associated with a significantly reduced concentration of calbindin-D,, in maternal intestine (7, (9) (10) (11) , and further evidence suggests that 1,25(OH),D3 regulates the expression of intestinal calbindin-D,, at both transcriptional and posttranscriptional levels (13, 14) . However, no study has addressed whether 1,25(OH),D3 affects placental calbindin-D,, expression at the mRNA level.
Although the use of the maternal intestinal response as a marker of maternal 1,25(OH),D3 status in the studies described above may be a reliable indicator of vitamin D deficiency (15) , without plasma vitamin D metabolite concentrations the degree of vitamin D deficiency in maternal and fetal compartments cannot be determined. This may be pertinent because rat placenta and fetal kidney have the capacity to synthesize 1,25(OH),D, in vitro (16) , with the former (17) but not the latter (18) source likely to be active in vivo.
The aim of this study was therefore to determine whether 1,25(OH),D3 does regulate calbindin-Dg, gene transcription in the rat chorioallantoic placenta. In these experiments, intestinal calbindin-D,, mRNA and maternal and fetal plasma concentrations of 25(OH)D3 and 1,25(OH),D3 were measured to determine vitamin D status. Vitamin D deficiency was induced by dietary means, and fetal calcium accretion was used as an index of net transplacental calcium flux.
METHODS

Animals and diets.
All procedures were carried out according to the Animals (Scientific Procedures) Act 1986. Threeweek-old Wistar rats from an in-house strain which rapidly develops vitamin D deficiency were fed a diet based on wholemeal flour with no added vitamin D (19) until 8 wk of age. They were then split into two groups of five, both of which were maintained on a synthetic diet based on white flour (19) but modified to be nonrachitogenic (calcium 0.5%, phosphorus 0.5% by weight). The +D group received 1 IU vitamin D (Koch-Light, Colnbrook, Berks, UK) per gram of diet in addition, whereas no further supplement was given to the -D group. Each group was fed their respective diets for 1 wk and then mated and maintained throughout pregnancy on the same diet that they had received during the week before mating.
Sample collection. On d 21 of gestation (d 1 taken to be the day a vaginal plug was found; term is 23 d), animals from both groups were anesthetized by ether inhalation. Maternal blood was collected from the inferior vena cava and fetal blood by axillary incision. Fetal plasma from all fetuses of each rat was pooled for analysis. Fetuses were removed and weighed.
Placentas were weighed and rapidly frozen in liquid nitrogen. Maternal duodenum (9 cm from pylorus) was removed, everted, rinsed in ice-cold saline, blotted, and rapidly frozen in liquid nitrogen. Both duodena and placentas were stored at -80°C before RNA extraction. Rats were killed immediately after completion of sampling.
Vitamin D metabolites. Plasma 25(OH)D3 and 1,25(OH),D3 concentrations were determined after extraction with acetonitrile and preliminary separation by HPLC. Concentrations of the metabolites were estimated by absorbance at 265 nm on a second HPLC separation for 25(OH)D3 (20) and by radioimmunoassay using a MAb for 1,25(OH),D3 (21) .
Fetal ashing. Four fetuses from each rat were separately ashed in a muffle furnace at 700°C overnight, ash weight was recorded, and the ash was dissolved in 3 mL 3 M HC1 for calcium determination (22) .
Calcium determinations. Plasma calcium concentration and fetal ash calcium content were determined by atomic absorption spectrophotometry, after dilution of samples with 1.33% LaC1,. Ionized calcium concentration in whole blood was measured using a calcium selective electrode (ICA1, Radiometer, Crowley, W. Sussex, UK).
RNA extraction and Northern blot analysis. Total RNA was extracted from placentas (three to five pooled from each rat) and maternal duodena of all rats in the +D and -D groups by the method of Chomczynski and Sacchi (23), as described previously (5) . Total RNA was fractionated on a 1.2% agarose/ formaldehyde gel and then transferred to a nylon filter (5) . RNA from tissues of +D and -D rats was always included on the same filter and on some filters, and for both tissues, RNA from more than one rat within the two experimental groups (+D and -D) was included. In some instances RNA from placenta or duodenum of an individual rat was hybridized more than once. Filters were prehybridized, hybridized with ,' Plabeled cDNA (24) for rat intestinal calbindin-D,, (25) , and then washed and autoradiographed as described previously (5) .
Filters were subsequently stripped and reprobed with p-actin cDNA which served as a control to correct for variations in sample loadings (5) . Preliminary studies showed that p-actin mRNA levels in duodenum and placenta, respectively, were not significantly different between the +D and -D groups (data not shown), in agreement with others (14) .
Quantitation of transcript density peak area was performed by spectrodensitometry (Shimadzu Scientific Instruments, Kyoto, Japan), and preliminary studies showed that hybridization signals were within the linear range of the film used. Relative calbindin-D,, mRNA abundance is reported as density values for calbindin-D,, mRNA normalized to density for p-actin mRNA.
Statistics. For plasma vitamin D metabolites and calcium determinations, n is the number of pregnant rats. For some animals, insufficient plasma was available for determination. For placental weight, fetal weight, fetal ash weight, and for fetal calcium content, respectively, an average value was determined for each pregnant rat, and n is the number of pregnant rats.
For Northern blot analyses, the relative calbindin-D9, mRNA abundance (calbindin-D,,/P-actin mRNA ratio) for each tissue from individual rats was determined and used for statistical comparison, and n is the number of hybridizations performed. To compare the difference in the relative calbindinDgK mRNA abundance (calbindin-D,,/P-actin mRNA ratio) between the +D and -D groups for both tissues, concurrent hybridizations were compared, and where more than one rat within the +D and -D groups was included on the same filter, a mean calbindin-D,,/P-actin mRNA ratio value for the + D and -D rats on that filter was used for statistical comparison and n is the number of filters hybridized. 
RESULTS
The vitamin D-deficient status of rats in the -D group was confirmed by the significant reduction in 25(OH)D, and 1,25(OH),D, concentration, respectively, in both maternal and fetal plasma (Table 1) .
Placental weight, fetal weight, fetal ash weight, ashed fetal calcium content, and total and ionized calcium concentrations in maternal and fetal plasma were similar in the +D and -D groups ( Table 2 ). Total and ionized calcium concentrations in fetal plasma were significantly higher than maternal in both +D and -D groups, and this maternofetal difference was unaffected by vitamin D deficiency ( Table 2) .
Northern hybridization studies identified a single calbindin-D,, transcript corresponding to 0.6 kb in both maternal duodenum and placenta (Fig. 1A) . The relatively greater abundance of mRNA for calbindin-D,, in duodenum compared with placenta was reflected by the shorter exposure time for the former ( Fig. 1 ) and is consistent with the 6-fold higher tissue calbindin-D,, concentration in the former at this gestational age (26) . The abundance of mRNA for calbindin-D,, in the duodenum was markedly lower in a vitamin D-deficient rat than in a vitamin D-replete rat, but there was no difference in calbindin-D,, mRNA abundance between the placentas of these two same animals (Fig. 1A) . P-Actin transcripts of 2.1 kb were identified in both tissues, with higher expression in placenta compared with duodenum, as indicated by the shorter exposure time for the former (Fig. 1B) . Figure 2 shows all hybridization signals and calbindin-D,,/ p-actin mRNA density ratios for both groups of rats. In every hybridization performed, calbindin-D,, mRNA abundance (normalized to p-actin) in duodenum was lower in the -D group compared with the +D group ( Fig. 2A) , this diminution ranging from -38 to -87%, such that mRNA abundance was 68 +-9% (n = 5) lower in the -D group (significant at the 6% level; Wilcoxon signed rank test). However, in placenta there was no consistent trend in the difference between calbindin-D, , mRNA abundance of the -D group compared with the +D group (Fig. 2B ), values ranging from -14 to +52%, the overall change being +13 + 22% (n = 4; not significant). The change in placenta was significantly different from that in 
Figure 1. Northern analysis o f calbindin-D,, and p-actin m R N A in maternal duodenum (MD) and placenta (P) o f two individual rats, one fed a +D and one fed a -D diet. Maternal plasma concentration of 1,25(OH),D, was 169 and 42 pM, respectively, and fetal plasma concentration of 1,25(OH),D, was 117 and 31 pM, respectively, for these individual +D and -D rats. Total R N A (15 &lane) was hybridized with cDNA for: (A) rat calbindin-D,, followed by autoradiography for 0.75 h (MD) or 4.5 h (P) and then (B) p-actin followed by autoradiography for 18.5 h (MD) or 6 h (P). Position of R N
DISCUSSION
The present study was carried out to determine whether calbindin-D,, mRNA expression is regulated by vitamin D in Density ratio values (27) and calbindin-D,, mRNA (28) within the labyrinth layer of rat placenta. The present findings support previous observations from dietary studies in which cytosolic calbindin-D,, protein concentration was reduced in maternal intestine but unaltered in placenta in response to vitamin D deficiency (10, 11) . Furthermore, they suggest that the reduction in placental calbindin-D,, concentration associated with thyroparathyroidectomy (7), diabetes (8) , and a high cation diet (9) is not directly related to a lowered maternal 1,25(OH),D3 concentration.
Our data also show that vitamin D deficiency did not impair fetal growth or mineralization, or alter the maternofetal plasma or whole blood ionized calcium concentration difference. This confirms previous observations that net placental calcium transport in the rat is not regulated by vitamin D (29, 30) .
These data therefore provide further support for the hypothesis that change, or as here, lack of change in calbindin-D,, mRNA expression is always coincident with any change in maternofetal calcium flux across the placenta (5, 6) .
Steroid hormones regulate gene expression by the interaction of the receptor-steroid complex with specific DNA sequences, hormone-responsive elements, located in or near the responsive genes (reviewed in Ref. 31 ). The identification of two different hormone-responsive elements in the rat calbindin-D,, gene, a 1,25(0H),D3-responsive element (32) , and an estrogen-responsive element (33) may confer hormonespecific transcriptional regulation of this gene in different tissues. Indeed, the expression of the calbindin-D,, gene in rat intestine is regulated by 1,25(OH),D3 and not by estrogen (34, 35) whereas in rat uterus it appears to be regulated by estrogen (33, 35, 36) and not by 1,25(OH),D3 (34) . In rat lung neither hormone appears to regulate the expression of this gene (35) .
The regulation of the calbindin-D,, gene in any one tissue may be multifactorial as suggested by a dietary study demonstrating that the stimulation by 1,25(OH),D3 of duodenal calbindin-D,, biosynthesis appears to be dependent on both prior vitamin D and calcium status (37) , and by in vitro studies confirming that both calcium and 1,25(OH),D3 stimulate calbindin-D,, gene expression in rat enterocytes (38) . This may GLAZIER ET AL. account for the apparently disparate observations in nonpregnant rats, in which intestinal calbindin-D9, concentration appeared to be significantly lower after dietary-induced vitamin D deficiency in some studies (15, 39, 40) but not in others (10, 41) . In this context, placental calbindin-D9, expression is unlikely to be directly modulated by maternal calcemia as both hypocalcemia (42) and hypercalcemia (9) elicited a marked decrease in placental calbindin-D9, concentration (8, 9) .
The coordinated induction of calbindin-D,, expression in uterus, placenta, and yolk sac, during the last third of gestation in the rat (43), suggests that the calbindin-D9, gene in these three closely apposed tissues may be regulated by a common hormone, possibly estrogen. In summary, the factors which control steady state calbindin-D9, mRNA expression in rat placenta have yet to be elucidated, and may be tissue-specific, but do not include 1,25(OH),D3.
